LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 161 filers reported holding LOXO ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 1.63 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,401,000 | -83.6% | 10,000 | -80.0% | 0.16% | -81.3% |
| Q3 2018 | $8,542,000 | -60.0% | 50,000 | -59.3% | 0.86% | -60.8% |
| Q2 2018 | $21,331,000 | +146.5% | 122,961 | +63.9% | 2.18% | +104.6% |
| Q1 2018 | $8,653,000 | +13.9% | 75,000 | -16.9% | 1.07% | +3.9% |
| Q4 2017 | $7,600,000 | +10.0% | 90,280 | +20.4% | 1.03% | +16.4% |
| Q3 2017 | $6,909,000 | – | 75,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |